Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

HMS faculty, help us improve the algorithms in Profiles by uploading your CV!

Tanuja Chitnis, M.D.

Co-Author

This page shows the publications co-authored by Tanuja Chitnis and Eric Klawiter.
Connection Strength

0.637
  1. High risk of postpartum relapses in neuromyelitis optica spectrum disorder. Neurology. 2017 Nov 28; 89(22):2238-2244.
    View in: PubMed
    Score: 0.178
  2. Female hormonal exposures and neuromyelitis optica symptom onset in a multicenter study. Neurol Neuroimmunol Neuroinflamm. 2017 May; 4(3):e339.
    View in: PubMed
    Score: 0.170
  3. Positive Predictive Value of MOG-IgG for Clinically Defined MOG-AD Within a Real-World Cohort. Front Neurol. 2022; 13:947630.
    View in: PubMed
    Score: 0.061
  4. Prospective growth and developmental outcomes in infants born to mothers with multiple sclerosis. Mult Scler. 2021 01; 27(1):79-89.
    View in: PubMed
    Score: 0.052
  5. Collaborative International Research in Clinical and Longitudinal Experience Study in NMOSD. Neurol Neuroimmunol Neuroinflamm. 2019 09; 6(5):e583.
    View in: PubMed
    Score: 0.050
  6. Collaborative International Research in Clinical and Longitudinal Experience Study in NMOSD. Neurol Neuroimmunol Neuroinflamm. 2019 Sep; 6(5).
    View in: PubMed
    Score: 0.050
  7. Update on biomarkers in neuromyelitis optica. Neurol Neuroimmunol Neuroinflamm. 2015 Aug; 2(4):e134.
    View in: PubMed
    Score: 0.038
  8. Use of Advanced Magnetic Resonance Imaging Techniques in Neuromyelitis Optica Spectrum Disorder. JAMA Neurol. 2015 Jul; 72(7):815-22.
    View in: PubMed
    Score: 0.038
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.